期刊
LANCET ONCOLOGY
卷 22, 期 4, 页码 E136-E172出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(20)30751-8
关键词
-
类别
资金
- National Insitutes of Health National Cancer Institute Cancer Center support grant [P30 CA008748]
- National Insitutes for Health National Cancer Institute grant [R35 CA232130]
- National Health and Medical Research Council grant [1177837]
- Harvard TH Chan School of Public Health
- African Association of Nuclear Medicine
- American College of Radiology
- Association of Latin American Societies of Biology and Nuclear Medicine
- Australian and New Zealand Society of Nuclear Medicine
- Asia Oceania Federation of Nuclear Medicine and Biology
- African Organisation for Research AMP
- Training in Cancer
- American Society of Clinical Oncology
- Arab Society of Nuclear Medicine
- African Society of Radiology
- American Society for Radiation Oncology
- Breast Cancer Research Foundation
- European Association of Nuclear Medicine
- European Society for Medical Oncology
- European Society of Radiology
- European Society for Radiotherapy and Oncology
- Hong Kong College of Radiologists
- International Atomic Energy Agency
- International Society for Strategic Studies in Radiology
- International Society of Radiology
- National Cancer Institute
- Pan-Arab Association of Radiological Societies
- Radiological Society of North America
- South African Society of Nuclear Medicine
- Society of Nuclear Medicine AMP
- Molecular Imaging
- Union for International Cancer Control
- World Federation of Nuclear Medicine and Biology
- World Molecular Imaging Society
The study demonstrates that the scale-up of imaging technology can significantly reduce cancer-related deaths globally and save a substantial number of life-years. Comprehensive scaling up of imaging, treatment, and care quality can save billions of dollars globally between 2020 and 2030, alleviating the global burden of cancer.
The diagnosis and treatment of patients with cancer requires access to imaging to ensure accurate management decisions and optimal outcomes. Our global assessment of imaging and nuclear medicine resources identified substantial shortages in equipment and workforce, particularly in low-income and middle-income countries (LMICs). A microsimulation model of 11 cancers showed that the scale-up of imaging would avert 3?2% (2?46 million) of all 76?0 million deaths caused by the modelled cancers worldwide between 2020 and 2030, saving 54?92 million lifeyears. A comprehensive scale-up of imaging, treatment, and care quality would avert 9?55 million (12?5%) of all cancer deaths caused by the modelled cancers worldwide, saving 232?30 million life-years. Scale-up of imaging would cost US$6?84 billion in 2020?30 but yield lifetime productivity gains of $1?23 trillion worldwide, a net return of $179?19 per $1 invested. Combining the scale-up of imaging, treatment, and quality of care would provide a net benefit of $2?66 trillion and a net return of $12?43 per $1 invested. With the use of a conservative approach regarding human capital, the scale-up of imaging alone would provide a net benefit of $209?46 billion and net return of $31?61 per $1 invested. With comprehensive scale-up, the worldwide net benefit using the human capital approach is $340?42 billion and the return per dollar invested is $2?46. These improved health and economic outcomes hold true across all geographical regions. We propose actions and investments that would enhance access to imaging equipment, workforce capacity, digital technology, radiopharma ceuticals, and research and training programmes in LMICs, to produce massive health and economic benefits and reduce the burden of cancer globally.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据